Hanretty K, Whittle M, McGowan L
Pharmatherapeutica. 1985;4(5):319-21.
A study was carried out in 40 women undergoing labour to investigate the effect of 100 to 150 mg meptazinol intramuscularly, given alone for the relief of labour pain, on fetal heart rate patterns. Patients were monitored continuously using a fetal scalp electrode attached to a fetal monitor, and fetal heart rate patterns recorded on the cardiotocograph. Traces were interpreted for 2 hours preceding and 2 hours after administration of meptazinol using a 12-point scoring system to quantify the variables of baseline rate and variability and the presence or absence of variable or late decelerations. All babies were born live and, except for 1 delivered by emergency caesaraen section under general anaesthesia, none had an Apgar score less than 8 at 1 minute. Analysis of the cardiotocograph traces showed that adverse changes, such as loss of variability, were not significantly associated with the use of meptazinol.
对40名待产妇女进行了一项研究,以调查单独肌内注射100至150毫克美普他酚缓解分娩疼痛对胎儿心率模式的影响。使用连接到胎儿监护仪的胎儿头皮电极对患者进行连续监测,并将胎儿心率模式记录在胎心监护仪上。在使用12分评分系统对美普他酚给药前2小时和给药后2小时的记录进行解读,以量化基线率和变异性变量以及是否存在变异或晚期减速。所有婴儿均存活出生,除1例在全身麻醉下紧急剖宫产分娩外,无一例在1分钟时Apgar评分低于8分。对胎心监护仪记录的分析表明,诸如变异性丧失等不良变化与美普他酚的使用无显著相关性。